Prophylactic OKT3 monoclonal antibody versus antilymphocyte globulins: a prospective, randomized study in 148 first cadaver kidney grafts.
Broyer
M
M
Department of Pediatric Nephrology, Hôpital Necker Enfants Malades, Paris, France.
Gagnadoux
M F
MF
Guest
G
G
Arsan
A
A
Beurton
D
D
Revillon
Y
Y
Niaudet
P
P
D000206:Actuarial Analysis; D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D015994:Incidence; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011446:Prospective Studies; D014777:Virus Diseases / Q000453:epidemiology / Q000209:etiology
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D003404:Creatinine